Home
>
National Drug Code (NDC)
>
Reclast
Reclast - 0078-0435-61 - (zoledronic acid)
Drug Information of Reclast
| Product NDC: | 0078-0435 |
| Proprietary Name: | Reclast |
| Non Proprietary Name: | zoledronic acid |
| Active Ingredient(s): | 5 mg/100mL & nbsp; zoledronic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Reclast
| Product NDC: | 0078-0435 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021817 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20070401 |
Package Information of Reclast
| Package NDC: | 0078-0435-61 |
| Package Description: | 100 mL in 1 BOTTLE (0078-0435-61) |
NDC Information of Reclast
| NDC Code | 0078-0435-61 |
| Proprietary Name | Reclast |
| Package Description | 100 mL in 1 BOTTLE (0078-0435-61) |
| Product NDC | 0078-0435 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zoledronic acid |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20070401 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ZOLEDRONIC ACID |
| Strength Number | 5 |
| Strength Unit | mg/100mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
